Clinical Trial Update: Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors

View source ↗

Summary

This clinical trial update concerns the evaluation of antiangiogenic effects of Bacillus Calmette-Guérin (BCG) in bladder cancer. The study appears to have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• BCG (Bacillus Calmette-Guérin)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Bladder Cancer | Status: TERMINATED